These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17918788)

  • 1. Improvement and longterm maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritis.
    Mittendorf T; Dietz B; Sterz R; Kupper H; Cifaldi MA; von der Schulenburg JM
    J Rheumatol; 2007 Dec; 34(12):2343-50. PubMed ID: 17918788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
    Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D
    J Rheumatol; 2012 Jan; 39(1):63-72. PubMed ID: 22045836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate.
    Torrance GW; Tugwell P; Amorosi S; Chartash E; Sengupta N
    Rheumatology (Oxford); 2004 Jun; 43(6):712-8. PubMed ID: 15039494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
    Loftus EV; Feagan BG; Colombel JF; Rubin DT; Wu EQ; Yu AP; Pollack PF; Chao J; Mulani P
    Am J Gastroenterol; 2008 Dec; 103(12):3132-41. PubMed ID: 18853973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.
    Kimel M; Cifaldi M; Chen N; Revicki D
    J Rheumatol; 2008 Feb; 35(2):206-15. PubMed ID: 18085743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
    J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis.
    Mok CC; Lok EY; Cheung EF
    Scand J Rheumatol; 2012 Aug; 41(4):253-9. PubMed ID: 22657161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
    Revicki DA; Luo MP; Wordsworth P; Wong RL; Chen N; Davis JC;
    J Rheumatol; 2008 Jul; 35(7):1346-53. PubMed ID: 18484692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis.
    Yount S; Sorensen MV; Cella D; Sengupta N; Grober J; Chartash EK
    Clin Exp Rheumatol; 2007; 25(6):838-46. PubMed ID: 18173917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab.
    Herenius MM; Hoving JL; Sluiter JK; Raterman HG; Lems WF; Dijkmans BA; Tak PP; Nurmohamed MT; Voskuyl AE; Frings-Dresen MH
    J Occup Environ Med; 2010 Jun; 52(6):618-21. PubMed ID: 20523240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
    Davis JC; Revicki D; van der Heijde DM; Rentz AM; Wong RL; Kupper H; Luo MP
    Arthritis Rheum; 2007 Aug; 57(6):1050-7. PubMed ID: 17665483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
    Rigby W; Ferraccioli G; Greenwald M; Zazueta-Montiel B; Fleischmann R; Wassenberg S; Ogale S; Armstrong G; Jahreis A; Burke L; Mela C; Chen A
    Arthritis Care Res (Hoboken); 2011 May; 63(5):711-20. PubMed ID: 21557525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Work ability: a new outcome measure in rheumatoid arthritis?
    Raterman HG; Hoving JL; Nurmohamed MT; Herenius MM; Sluiter JK; Lems WF; Tak PP; Dijkmans BA; Twisk J; Frings-Dresen MH; Voskuyl AE
    Scand J Rheumatol; 2010 Mar; 39(2):127-31. PubMed ID: 20059369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab improves sleep and sleep quality in patients with active ankylosing spondylitis.
    Rudwaleit M; Gooch K; Michel B; Herold M; Thörner A; Wong R; Kron M; Chen N; Kupper H
    J Rheumatol; 2011 Jan; 38(1):79-86. PubMed ID: 20952469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
    Emery P; Kosinski M; Li T; Martin M; Williams GR; Becker JC; Blaisdell B; Ware JE; Birbara C; Russell AS
    J Rheumatol; 2006 Apr; 33(4):681-9. PubMed ID: 16568505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation.
    Hoving JL; Bartelds GM; Sluiter JK; Sadiraj K; Groot I; Lems WF; Dijkmans BA; Wijbrandts CA; Tak PP; Nurmohamed MT; Voskuyl AE; Frings-Dresen MH
    Scand J Rheumatol; 2009; 38(4):246-50. PubMed ID: 19337948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.
    Heiberg MS; Nordvåg BY; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
    Arthritis Rheum; 2005 Aug; 52(8):2506-12. PubMed ID: 16052584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis.
    Wells G; Li T; Maxwell L; Maclean R; Tugwell P
    Ann Rheum Dis; 2008 Feb; 67(2):260-5. PubMed ID: 17846044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.